E-LIB Suche - Ergebnisse für: Shiratori, Yasushi

1

An open‐label study of belumosudil, a selective ROCK2 inhib..:

Inamoto, Yoshihiro ; Kato, Koji ; Kawakita, Toshiro...
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

2

Efficacy of Pembrolizumab Monotherapy in Japanese Patients ..:

Muro, Kei ; Shitara, Kohei ; Yamaguchi, Kensei...
Journal of Gastrointestinal Cancer. 54 (2023) 3 - p. 951-961 , 2023

Link: https://doi.org/10.1007/..

3

Advantages of enhanced recovery after surgery program in ro..:

Nakamura, Masaki ; Tsuru, Ibuki ; Izumi, Taro...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

Efficacy of Pembrolizumab Monotherapy in Japanese Patients ..:

Muro, Kei ; Shitara, Kohei ; Yamaguchi, Kensei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613141/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Advantages of enhanced recovery after surgery program in ro..:

Masaki Nakamura ; Ibuki Tsuru ; Taro Izumi...
https://doi.org/10.1038/s41598-023-43489-w. , 2023

Link: https://doi.org/10.1038/..

6

Advantages of enhanced recovery after surgery program in ro..:

Nakamura, Masaki ; Tsuru, Ibuki ; Izumi, Taro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533885/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antith..:

Shiratori, Souichi ; Kurata, Mio ; Sugita, Junichi...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S293-S294 , 2022

Link: https://doi.org/10.1016/..

8

PhaseIIbstudy of pembrolizumab combined with S‐1 + oxalipla..:

Yamaguchi, Kensei ; Minashi, Keiko ; Sakai, Daisuke...
Cancer Science. 113 (2022) 8 - p. 2814-2827 , 2022

Link: https://doi.org/10.1111/..

9

Phase IIb study of pembrolizumab combined with S‐1 + oxalip..:

Yamaguchi, Kensei ; Minashi, Keiko ; Sakai, Daisuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357620/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Improved survival of patients with aggressive ATL by increa..:

Ito, Ayumu ; Nakano, Nobuaki ; Tanaka, Takashi...
Blood Advances. 5 (2021) 20 - p. 4156-4166 , 2021

Link: https://doi.org/10.1182/..

11

Low-dose antithymocyte globulin inhibits chronic graft-vers..:

Shiratori, Souichi ; Sugita, Junichi ; Fuji, Shigeo...
Bone Marrow Transplantation. 56 (2021) 9 - p. 2231-2240 , 2021

Link: https://doi.org/10.1038/..

12

Measurable residual disease affects allogeneic hematopoieti..:

Nishiwaki, Satoshi ; Akahoshi, Yu ; Mizuta, Shuichi...
Blood Advances. 5 (2021) 2 - p. 584-592 , 2021

Link: https://doi.org/10.1182/..

13

Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antith..:

Shiratori, Souichi ; Kurata, Mio ; Sugita, Junichi...
Transplantation and Cellular Therapy. 27 (2021) 12 - p. 995.e1-995.e6 , 2021

Link: https://doi.org/10.1016/..

14

Efficacy and safety of micafungin in empiric and D-index-gu..:

Kimura, Shun-ichi ; Kanda, Yoshinobu ; Iino, Masaki...
http://repo.lib.tokushima-u.ac.jp/files/public/11/116538/20211122161424451131/ijid_100_292.pdf. , 2021

Link: http://repo.lib.tokushim..

15

Measurable residual disease affects allogeneic hematopoieti..:

Nishiwaki, Satoshi ; Akahoshi, Yu ; Mizuta, Shuichi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839376/. , 2021

Link: http://www.ncbi.nlm.nih...